The molecular signaling that underpins synapse loss in neuropathological conditions remains unknown. Concomitant upregulation of the neuronal nitric oxide (NO) synthase (nNOS) in neurodegenerative processes places NO at the center of attention. We found that de novo nNOS expression was sufficient to induce synapse loss from motoneurons at adult and neonatal stages. In brainstem slices obtained from neonatal animals, this effect required prolonged activation of the soluble guanylyl cyclase (sGC)/protein kinase G (PKG) pathway and RhoA/Rho kinase (ROCK) signaling. Synapse elimination involved paracrine/retrograde action of NO. Furthermore, before bouton detachment, NO increased synapse myosin light chain phosphorylation (p-MLC), which is known to trigger actomyosin contraction and neurite retraction. NO-induced MLC phosphorylation was dependent on cGMP/PKG-ROCK signaling. In adulthood, motor nerve injury induced NO/cGMP-dependent synaptic stripping, strongly affecting ROCK-expressing synapses, and increased the percentage of p-MLCexpressing inputs before synapse destabilization. We propose that this molecular cascade could trigger synapse loss underlying early cognitive/motor deficits in several neuropathological states.
Introduction
Synapse loss, rather than cell death, is the main factor underlying cognitive decline in Alzheimer's disease (AD) (Palop et al., 2006; Small, 2008 ), Parkinson's disease (PD) (Emre, 2003) , Huntington's disease (HD) (Cepeda et al., 2007) , multiple sclerosis (MS) (Centonze et al., 2009) , and HIV dementia (Kim et al., 2008) in patients and/or in animal models. Synaptic stripping from the motoneuron surface also occurs in the progression of several motoneuron pathologies, such as amyotrophic lateral sclerosis (ALS), progressive muscular atrophy, and traumatically damaged adult motor axons (Sumner, 1975; Ikemoto et al., 1994; Sasaki and Maruyama, 1994; Ince et al., 1995; Sunico et al., 2005) . Understanding the molecular basis underlying this neurodegenerative event is of central interest for the development of new therapeutic tools. Several findings point to the short half-life gas nitric oxide (NO) as a key molecule in detrimental synaptic changes. Upregulation of neuronal NO synthase (nNOS) is a common hallmark, occurring in motoneurons and reactive astrocytes in ALS (Anneser et al., 2001; Catania et al., 2001; Sasaki et al., 2001) , in neurons and/or glial cells in PD and AD (Eve et al., 1998; Lüth et al., 2000; Simic et al., 2000; Fernández-Vizarra et al., 2004) , and in the striatum of HD models at early stages (Deckel et al., 2002; Pérez-Severiano et al., 2002) . iNOS (inducible NOS) is also upregulated in glial cells in these diseases as well as in MS and HIV dementia (Lee et al., 2003) . Additionally, NO participates in projection refinement during development (Wu et al., 1994) and in synapse loss suffered by motoneurons after motor nerve injury (Sunico et al., 2005; Moreno-Ló pez and González-Forero, 2006) . However, determining whether NO synthesis is not only necessary but also sufficient to induce synapse loss remains elusive.
The small Rho GTPase RhoA and its major effector Rho kinase (ROCK) could be firm partners of NO-directed synapse elimination during neuropathological progression: (1) RhoA/ ROCK mediates neurite retraction, preventing axon growth initiation, and dendrite retraction in different neuronal types in culture (Luo, 2000 (Luo, , 2002 ; (2) activity of ROCK and protein kinase G (PKG), a downstream NO/cGMP effector, mediates semaphorin 3A-induced growth cone collapse (Dontchev and Letourneau, 2002) ; (3) RhoA upregulation occurs in neurons surrounding amyloid plaques and an increase in phosphorylation of RhoA/ROCK substrates is involved in ␤-amyloid (A␤)-induced inhibition of neurite outgrowth and synapse formation in a model of AD (Heredia et al., 2006; Petratos et al., 2008) ; and (4) RhoA/ROCK regulates fiber contraction by enhancing myosin light chain phosphorylation (p-MLC). In this way, RhoA/ROCK signaling, directly and/or indirectly activating MLC-kinase, phosphorylates MLC. It then induces actomyosin contraction and neu-
Extraction of brainstem slices for in vitro experiments
Rat pups (P6 -P9) were anesthetized by hypothermia (placing on ice for 10 -15 min) and decapitated, and their brainstems quickly removed. Dissection was in ice-cold (Ͻ4°C) sucrose artificial CSF (S-aCSF) bubbled with 95% O 2 and 5% CO 2 . S-aCSF composition was as follows (in mM): 26 NaHCO 3 , 10 glucose, 3 KCl, 1.25 NaH 2 PO 4 , 2 MgCl 2 , and 218 sucrose. Transverse slices (300 to 400 m thick) were obtained using a vibroslicer (NVSL; WPI). Slices were transferred to normal oxygenated aCSF (in mM: 26 NaHCO 3 , 10 glucose, 3 KCl, 1.25 NaH 2 PO 4 , 2 MgCl 2 , 130 NaCl, and 2 CaCl 2 ) and allowed to stabilize at ϳ37°C for 1 h. Next, slices were incubated for an additional period of 1-6 h (ϳ22°C) with aCSF supplemented with different drugs before histological processing, whole-cell patch-clamp recordings, or tissue extraction for Western blotting experiments.
Histological procedures
For confocal microscopy. Animals were anesthetized with chloral hydrate, injected intraventricularly with heparin, and perfused transcardially first with PBS, followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB), pH 7.4, at 4°C. The brains were removed and postfixed for 2 h in the same fixative solution. Brainstem slices (350 m thick) were incubated for 6 h with drugs, and then fixed by 30 min immersion in 4% PFA at 4°C. Both brains and brainstem slices were cryoprotected by overnight immersion in 30% sucrose in 0.1 M PB at 4°C. Serial coronal sections (30 m thick) were obtained from both types of specimen using a cryostat and stored at Ϫ20°C in a cryoprotectant solution (glycerol/ PBS, 1:1 v/v).
Immunohistochemistry was performed against synaptophysin (syn), vesicular glutamate (VGLUT2), and/or GABA (VGAT) transporters as synaptic markers; ROCK␣ and ROCK␤; p-MLC; and/or the nonphosphorylated form of neurofilament H (SMI32) as a motoneuron marker. Sections were rinsed in PBS and immersed in 2.5% (w/v) bovine serum albumin, 0.25% (w/v) sodium azide, and 0.1% (v/v) Triton X-100 in PBS for 30 min, followed by overnight incubation at 4°C with different combinations of up to three antisera. Polyclonal primary antibodies used in this study were as follows: anti-syn (1:200; Zymed Laboratories), anti-VGAT (1:2000; Millipore Bioscience Research Reagents), and anti-p-MLC (1:125; Cell Signaling) developed in rabbit; anti-VGLUT2 (1:2500; Millipore Bioscience Research Reagents) developed in guinea pig; antip-MLC (1:250), anti-ROCK␣ (1:100), and anti-ROCK␤ (1:50; Santa Cruz Biotechnology) developed in goat; and anti-SMI32 (1:8000; Covance) developed in mouse. Subsequently, the tissue was rinsed three times with PBS for 5 min each and incubated for 2 h at room temperature with the secondary antibodies, developed in donkey: anti-guinea pig, anti-goat, anti-mouse, or anti-rabbit IgGs labeled with the cyanine 2, 3, or 5 (Cy2, Cy3, Cy5) (1:400; Jackson ImmunoResearch Laboratories). Finally, sections were washed with PBS and mounted on slides with a solution containing propyl gallate (0.1 mM in PBS/glycerol, 1:9 v/v). Omission of the primary antibodies resulted in no detectable staining.
Slides were analyzed using a Leica confocal microscope for fluorescence. All motoneurons were analyzed in a z-plane containing the nucleus. The pinhole opening (1 Airy unit) was the same for all experimental conditions.
For electron microscopy. Adult rats transfected with adenovirus were deeply anesthetized with chloral hydrate. The animals then received intraventricular heparin injection and transcardial perfusion with PBS, followed by 4:0.5% PFA/glutaraldehyde (GLUT) in 0.1 M PB, pH 7.4, at 4°C. Brainstems were removed and postfixed overnight in 4% PFA. Next, coronal sections, 30 -40 m thick, were cut in a vibratome. Brainstem slices (300 m thick), incubated for 6 h with drugs, were fixed by overnight immersion in 2:2.5% PFA/GLUT in 0.1 M PB, pH 7.4, at 4°C. Slices were stored in PB with 0.05% sodium azide at 4°C until electron microscopy processing.
Initially, eGFP-transfected motoneurons were identified in the slices under an epifluorescence microscope (Nikon Eclipse E800), and images were captured using a digital camera (Nikon FDX 35) for subsequent localization. Next, brainstem sections were incubated in 1% sodium borohydride in PBS for 30 min. Tissue was then rinsed in PBS and cryoprotected by immersion in 25% sucrose in PBS (30 min), followed by six to eight quick immersions (ϳ2 s each) in 2-methylbutane at Ϫ60°C. After washing, nonspecific labeling was blocked by 1 h incubation with 3% Aurion-BSAc (Electron Microscopy Sciences) in PBS, followed by 60 h incubation at 4°C, with specific chicken anti-GFP IgY antibody (1:200; Aves Labs). Subsequently, tissue was incubated for 1 h at room temperature with 5% Aurion-BSAc and 0.25% coldwater fish skin gelatin in PBS, followed by 24 h incubation with gold-coated IgG goat antichicken antibody (1:50; Electron Microscopy Sciences). Slices were then washed with 2% sodium acetate in PBS, developed with Aurion R-Gent silver enhancement kit (Electron Microscopy Sciences), and washed again with 2% sodium acetate in PBS. Labeling was enhanced with 0.05% gold chloride solution (Electron Microscopy Sciences), stabilized with 0.3% sodium thiosulfate, and washed with PBS. Finally, slices were fixed again with 2% GLUT for 40 min, and then stored in PB with 0.05% sodium azide at 4°C.
For ultrastructural studies, sections were washed in 0.1 M PB and postfixed with 2% osmium tetroxide in 0.1 M PB for 90 min. Subsequently, the slices were rinsed with distilled water, dehydrated in graded series of ethanol including 30% (5 min), 50% (5 min), and 70% (10 min), and stained for 2 h 30 min in 2% uranyl acetate in 70% ethanol at 4°C. Afterward, sections were dehydrated again in graded series of ethanol including 70 (5 min), 96, and 100%, washed with propylene oxide, embedded in Araldite resin, and left to polymerize for at least 72 h at 70°C. Ultrathin sections (70 -80 nm thick) obtained by an ultramicrotome (Leica EM UC6) were analyzed under a FEI Tecnai Spirit electron microscope at high magnification (43,000ϫ) attached to a digital camera (Morada Preview). Captured images were analyzed off-line using the Image Tool software. Motoneurons were analyzed at the level of the nucleolus, except for experiments using Avs, in which analyses were performed at the level of the nucleus.
Whole-cell patch-clamp recordings
The slices were individually transferred into the recording chamber and perfused continuously (at a rate of 2 ml/min) with different solutions at 31°C. Whole-cell recordings were obtained from somata of HMNs visually identified based on location and characteristic size and shape (González-Forero et al., 2007 ) using a Nikon Eclipse CFI60 microscope equipped with infrared-differential interference contrast (IR-DIC), a 40ϫ water-immersion objective, and an IR camera system (TILL Photonics). eGFP-transfected HMNs were identified by epifluorescence. Patch pipettes were pulled from 1.5 mm outer diameter borosilicate glass using a PP-830 puller (Narishige). Patch electrodes (1.5-3 M⍀ resistance) contained the following (in mM): 17.5 KCl, 122.5 K-gluconate, 9 NaCl, 1 MgCl 2 , 10 HEPES, 0.2 EGTA, 3 Mg-ATP, 0.3 GTP-Tris with pH buffered to 7.2.
Electrically evoked EPSPs were elicited with a single concentric bipolar tungsten electrode located 0.5-1 mm from the hypoglossal nucleus (HN) in the ventrolateral reticular formation (VLRF). The stimulus frequency was kept low enough to avoid short-term changes in synaptic responses (0.5-1 Hz). Stimulus duration was 50 s. Stimulus intensity was five times the threshold stimulation. In each HMN, the stimulus threshold for EPSP was determined as the minimal stimulus intensity required to elicit a detectable EPSP in Ͼ50% of cases. A supramaximal stimulus intensity at fivefold the threshold stimulation (Ͻ400 A) was chosen because it evoked EPSPs of maximal and fairly constant amplitude. Current-clamp recordings were obtained and low-pass Bessel filtered at 10 kHz with a MultiClamp 700B amplifier. Data were digitized at 20 kHz with a Digidata 1332A analog-to-digital converter and acquired using pCLAMP 9.2 software (Molecular Devices). Overall, the mean input resistance of the recorded HMNs was 76.5 Ϯ 6.1 M⍀, with a range from 28.0 to 177.9 M⍀. Only recordings with an access resistance (Ͻ20 M⍀) of Ͻ25% of the mean input resistance (R N ) were considered acceptable for analysis. The access resistance was checked throughout the experiments, and recording was abandoned if it changed Ͼ15%. Series resistance was routinely compensated 65-75%. The pipette offset potential was zeroed before the cells were patched. Leak or liquid junction potentials were not corrected.
Western blotting
Slicing and microdissection of HNs were both performed in ice-cold (Ͻ4°C) S-aCSF supplemented with protease (1 mM phenylmethylsulfonyl fluoride, 10 mg/ml leupeptin, 10 mg/ml pepstatin A, 10 mg/ml aprotinin) and phosphatase inhibitors. Tissue slices from neonatal rat pups (P7) were obtained as described above and incubated (1, 2, 3, 4, or 6 h) in carbogen-bubbled aCSF alone (control) or containing a NO donor. Microdissected HNs were homogenized in lysis buffer [50 mM Tris/HCl, pH 7.4, 1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate] supplemented with protease and phosphatase inhibitors using a 1 ml syringe. Equal amounts of protein were processed for SDS-PAGE and immunoblotting, using a specific antibody against p-MLC and MLC developed in goat and rabbit, respectively (1:200; Santa Cruz Biotechnology). Membranes were also probed with anti-␣ 1 -tubulin antibody (1:250,000; Sigma-Aldrich) as control for the total amount of protein contained in each well. Analysis was performed using the ImageJ 1.36b software from the National Institutes of Health.
Drugs and treatments
Either alone or in different combinations, the following drugs were added to the incubation bath: the long half-life NO donor (
(1 mM; Sigma-Aldrich); the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (carboxy-PTIO) (300 M; Tocris Bioscience); the broad-spectrum NOS inhibitor N -nitro-L-arginine methyl ester (L-NAME) (2 mM; Sigma-Aldrich); the specific soluble guanylyl cyclase (sGC) inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (20 M; Sigma-Aldrich); the cGMP permeable analog 8-Br-cGMP (0.1 mM; Sigma-Aldrich); the specific protein kinase G inhibitor (PKG-i) guanosine, 3Ј,5Ј-cyclic monophosphorothioate, 8 -4-chlorophenylthio-, Rp-isomer (Rp-8-pCPT-cGMPS) (10 M; Calbiochem); the specific inhibitor of Rho exoenzyme C3 transferase (Exo C3) (2.5 g/ml; Cytoskeleton); and the specific inhibitors of ROCK trans-
Administration of chemicals in vivo began the day of crushing or adenoviral injection into the tongue. Rats were injected intraperitoneally (adults) or subcutaneously (pups) with L-NAME (90 mg ⅐ kg
. In our hands, the injected dose of L-NAME produced a transient increase in the arterial blood pressure that returned to control values 6 h after injection, and it was not altered by the nNOS inhibitor 7-NI. The amounts of nNOS and endothelial isoform of NOS remained as in control animals after chronic treatment with L-NAME . Both perfusion and slice extraction were performed at least 18 h after the last injection of chemicals, given that constitutive NOS inhibition persisted in Ͼ50% (Moreno-Ló pez et al., 2004) and to fully avoid acute effects of NOS inhibition on arterial blood pressure.
Statistics
Data are expressed as the mean Ϯ SEM. Unpaired two-tailed Student's t test or one-way ANOVA was used to compare two or more groups, respectively. When n Յ 5, as in electron microscopy of eGFP-transfected HMNs and immunoblot studies, the nonparametric Mann-Whitney U test was applied. Statistical significance was placed at p Ͻ 0.05. The number of analyzed HMNs and number of animals per experimental condition are indicated in figure legends.
Results

nNOS upregulation in adult motoneurons is "sufficient" to induce excitatory, but not inhibitory, synapse withdrawal
To investigate whether NO signaling is "sufficient" to trigger synapse loss, we used adenoviral vectors to transduce adult motoneurons with eGFP, mRFP, and/or nNOS. Injection of a mixture of two adenoviruses (Av-eGFP/Av-mRFP) into the tip of the tongue retrogradely transduced 10 -50 HMNs per animal ( Fig. 1 A, B) . Interestingly, a high frequency (92.7 Ϯ 5.2%; n ϭ 3 rats) of eGFP-transduced motoneurons also coexpressed mRFP. Thus, it was highly plausible that an eGFP-positive HMN was also nNOS-cotransduced after Av-eGFP/Av-nNOS coadministration. At the times tested, inspection of coronal brainstem sections did not reveal eGFP-or mRFP-positive neurons in projection areas to the HN, such as the VLRF or in the neighboring nucleus of tractus solitarii. This rules out the possibility of a direct premotor action of the adenoviral products. One week after adenoviral injection, the linear density of syn-immunoreactive (syn-ir) puncta of eGFP/mRFP-cotransduced motoneurons (17.6 Ϯ 0.65 puncta/100 m of membrane perimeter; n ϭ 67 HMNs from 3 rats) was similar to that measured in FG-backlabeled HMNs (18.9 Ϯ 0.72 puncta/100 m). This result dismisses the possibility of unwanted side effects of the transduction process on the synaptic coverage of infected HMNs. However, cotransduction of HMNs with Av-eGFP/Av-nNOS induced a significant ( p Ͻ 0.0001, unpaired two-tailed Student's t test) reduction in their synaptic coverage (13.3 Ϯ 0.47 puncta/100 m; n ϭ 108 HMNs from 4 rats) (Fig. 1C,D) . Results were not explained by changes in motoneuron size (Av-eGFP/Av-mRFP, 71.0 Ϯ 2.56 m; AveGFP/Av-nNOS, 72.0 Ϯ 1.39 m perimeter).
Axonal damage of adult motoneurons is followed by vesiclecontaining spherical (S-type), but not flat/pleomorphic (F/Ptype), synapse elimination (Sumner, 1975) . Given that S-type and F/P-type boutons are presumably excitatory and inhibitory, respectively (Gray, 1959; Bodian, 1966; Uchizono, 1965) , we determined whether this selective action is also induced by NO signaling. Next, immunohistochemistry was performed against VGLUT2, to identify a subtype of excitatory synaptic inputs, and VGAT, to label inhibitory terminals. Muscle administration of Av-eGFP had no effects on the linear density of excitatory (5.98 Ϯ 0.40 VGLUT2-ir puncta/100 m) and inhibitory (13.24 Ϯ 0.86 VGAT-ir puncta/100 m) puncta apposed to transfected HMNs relative to FG-identified motoneurons. Nevertheless, injection of Av-eGFP/Av-nNOS induced a drastic decrease in VGLUT2-ir (Ϫ34.6 Ϯ 7.9%) but not in VGAT-ir puncta (3.0 Ϯ 7.4%) (Fig. 1 E-G) .
These alterations could be the consequence of a NO-mediated disorganization of the synaptic machinery rather than the actual withdrawal of boutons. To solve this question, we studied, under electron microscopy, the synaptic coverage of transduced motoneurons identified by immunogold against eGFP (Fig. 1 H) . In our preparations, synaptic contacts did not show presynaptic and/or postsynaptic densities as thick as those described originally in the cerebral cortex (Gray, 1959) ; therefore, classification was done by type of synaptic vesicle. We distinguished between F/P-type (Fig. 1 I) and S-type (Fig. 1 J) boutons. In eGFP-positive motoneurons, most boutons contained clear F/P vesicles (31.8 Ϯ 5.08 boutons/100 m). The frequency of this type was not significantly altered by coadministration of Av-eGFP/Av-nNOS (34.3 Ϯ 2.80 boutons/100 m). As expected, the frequency of S-type boutons was selectively reduced (Ϫ85.4 Ϯ 6.51%) after transduction with Av-eGFP/Av-nNOS (0.9 Ϯ 0.86 vs 5.9 Ϯ 2.17 boutons/100 m in controls) (Fig. 1 K) . These data strongly support that nNOS upregulation in adult motoneurons is sufficient to induce the detachment of excitatory, but not inhibitory, synapses. Strikingly, ultrastructural analysis revealed that synaptic frequency of S-type boutons was reduced to a greater extent than VGLUT2-ir puncta detected by immunofluorescence. The reasons for this apparent discrepancy may lie in the fact that: (1) under confocal microscopy, we only analyzed puncta for VGLUT2, but not for VGLUT1; (2) single VGLUT2-ir puncta does not necessarily represent individual synaptic boutons; and (3) it is likely that our quantitative analysis of VGLUT2 staining on confocal images underestimates synaptic stripping because it does not allow to discriminate between boutons contacting the neuronal membrane and those that have been detached but remain in proximity to the soma.
Long-term action of NO/cGMP/PKG pathway reduces syn-ir puncta and evoked EPSPs in neonatal motoneurons
To characterize molecular partners acting downstream from NO in synaptic stripping, we incubated brainstem sections obtained from rat pups (P6 -P9) with several regulators of the NO/cGMP/ PKG cascade. The characteristic uninterrupted rhythmic discharge of adult HMNs in vivo would be expected to support a sustained production of NO in nNOS-transduced motoneurons. In an attempt to mimic this microenvironment, slices containing FG-labeled HMNs were preincubated (ϳ6 h) with a long half-life NONOate, DETA/NO, before immersion in the fixative solution. The linear density of syn-ir puncta apposed to DETA/NOsuperfused motoneurons was reduced (Ϫ48.9 Ϯ 1.7%) relative to control HMNs (25.9 Ϯ 0.93 puncta/100 m; ϳ6 h incubation in aCSF) (Fig. 2 A, B,E) . As in adults, results could not account for changes in the size of analyzed motoneurons (control, 61.9 Ϯ 1.49 m; DETA/NO, 63.1 Ϯ 1.25 m in perimeter). Reduction in the frequency of syn-ir puncta was avoided in slices coincubated with DETA/NO plus either the sGC inhibitor ODQ or the PKG-i Rp-8-pCPT-cGMPS (Fig. 2C,E) . Thus, NO-induced reduction in synaptic puncta apposed to motoneurons was mediated via sGC and PKG activation.
Functional correlations were studied by analyzing whole-cell patch-clamp recordings of the EPSPs evoked in HMNs by electrical stimulation of the VLRF (Fig. 2 F) . Corroborating histological findings, DETA/NO (for 5-6 h) induced a decrease (Ϫ43.1 Ϯ 4.5%) in the amplitude of the orthodromic excitatory synaptic potential relative to the aCSF incubation alone (Fig. 2G,H ) . Although the rise time of EPSPs (10 -90% of peak amplitude) tended to be slightly longer in DETA/NO-treated HMNs (con- Figure 2 . The NO/cGMP/PKG pathway reduces syn-ir puncta and the evoked EPSP in neonatal motoneurons in a RhoA/ROCK-dependent way. A-D, Syn-ir puncta around FG-identified HMNs obtained from slices incubated for 6 h as indicated. Scale bars, 10 m. Secondary antibody was labeled with Cy5 for immunolabeling of syn. E, Average number of Syn-ir puncta per 100 m of FG-identified HMN perimeter at the indicated conditions (aCSF, n ϭ 99 HMNs from 7 pups; DETA/NO, n ϭ 100 HMNs from 7 pups; DETA/NOϩODQ, n ϭ 100 HMNs from 7 pups; DETA/NOϩPKG-i, n ϭ 50 HMNs from 7 pups; Y27632, n ϭ 50 HMNs from 4 pups; DETA/NOϩY27632, n ϭ 50 HMNs from 6 pups; H1152, n ϭ 30 HMNs from 3 pups; DETA/NOϩH1152, n ϭ 30 HMNs from 3 pups). *p Ͻ 0.0001, one-way ANOVA test relative to the aCSF condition. F, Recordings (Rec) of EPSPs evoked in HMNs by electrical stimulation (St.) of the VLRF were performed by whole-cell patch clamp. G, Representative EPSPs (10 traces overlapped) recorded in HMNs after the indicated treatments. Membrane potential was held at Ϫ64 mV in all recorded motoneurons. The arrowheads point to stimulus artifact. H, Average EPSP amplitude recorded in HMNs under the indicated treatments (aCSF, n ϭ 12 HMNs from 5 pups; DETA/NO, n ϭ 19 HMNs from 4 pups; DETA/NOϩODQ, n ϭ 15 HMNs from 4 pups; DETA/NOϩPKG-i, n ϭ 20 HMNs from 7 pups; DETA/NOϩExo C3, n ϭ 14 HMNs from 5 pups; DETA/NOϩY27632, n ϭ 20 HMNs from 6 pups; DETA/NOϩH1152, n ϭ 14 HMNs from 4 pups). *p Ͻ 0.0001, one-way ANOVA test relative to the aCSF condition. Error bars indicate SEM. trol, 3.7 Ϯ 0.1 ms; DETA/NO, 4.6 Ϯ 0.5 ms), these differences did not reach statistical significance. We recently reported that longterm incubation with DETA/NO had a direct effect on the intrinsic excitability of HMNs through inhibition of leak potassium currents, which leads to increases in their R N (González-Forero et al., 2007) . This purely postsynaptic action on R N was also evidenced in the present study (50.5 Ϯ 5.4 M⍀ in control compared with 90.1 Ϯ 7.0 M⍀ in DETA/NO-treated HMNs; p Ͻ 0.001, unpaired two-tailed Student's t test). Consequently, postsynaptic changes in membrane excitability induced by DETA/NO would be expected to augment the magnitude of voltage responses induced by synaptic currents. Therefore, our measurements of EPSP amplitude in current-clamp recordings most likely underestimated the action of NO on synaptic strength. Functional disturbance induced by chronic presence of the NO donor was also avoided by coaddition to the bath of ODQ or PKG-i (Fig. 2G,H ) . Thus, long-term action of NO/sGC/PKG pathway caused synaptic stripping accompanied by a reduction in synaptic strength in neonatal HMNs.
NO-induced synapse elimination requires RhoA/ROCK activity and involves previous MLC phosphorylation
Since RhoA/ROCK is essential for neurite retraction in culture (Luo, 2000 (Luo, , 2002 , we tested for the dependence of the NOinduced synaptic remodeling on RhoA/ROCK activity. Longterm inhibition of endogenous ROCK activity by adding either of two specific inhibitors, Y27632 or H1152, to the bath did not modify the linear density of syn-ir puncta on HMNs (23.8 Ϯ 0.99 and 27.3 Ϯ 1.19 puncta/100 m, respectively) (Fig. 2 E) . However, coaddition to the bath of ROCK inhibitors prevented reduction of the number of puncta induced by DETA/NO (Fig. 2 D, E) . These morphological findings were indeed consistent with the electrophysiological analysis of EPSPs. The amplitude of the evoked EPSP in HMNs after long-term coincubation of slices with DETA/NO plus either Y27632, H1152, or the Rho inhibitor Exo C3 was similar to that obtained in motoneurons from slices incubated in aCSF (Fig. 2G,H ) . These results strongly indicate that the synaptic reorganization induced in HMNs by activation of the NO/PKG cascade depends on RhoA/ROCK signaling.
ROCK can phosphorylate MLC, a proposed mechanism underlying actomyosin contraction and neurite outgrowth retraction (Ramakers, 2002; Newey et al., 2005) . Immunoblot analysis revealed a time-dependent increase in the ratio of p-MLC to MLC in DETA/NO-relative to aCSF-incubated HN, reaching a maximal value 3-4 h after addition of the NO donor (Fig. 3 A, B) . Three hours after the beginning of treatment, DETA/NO induced a robust increase in the p-MLC/MLC ratio; however, syn-ir puncta frequency remained unaltered (Fig. 3 A, B) . Therefore, in- crease in p-MLC preceded syn-ir puncta reduction. In addition, at 6 h after DETA/NO treatment, the p-MLC/MLC ratio and the linear density of syn-ir puncta decreased in a similar proportion (ϳ43%), suggesting that the two processes are closely related. The NO donor did not alter total amount of MLC in the HN after 4 h of incubation (Fig. 3C) .
Subsequently, we analyzed syn-ir puncta coexpressing p-MLC after incubation for 3 h with different drugs (Fig. 3D-G) . Incubation with DETA/NO or the cell-permeable cGMP analog 8-BrcGMP almost doubled the number of syn-ir puncta colocalizing with p-MLC-ir structures around HMNs (Fig. 3 D, G) . The NO/ cGMP-induced increase in p-MLC was prevented by coaddition to the bath of PKG or ROCK inhibitors (Fig. 3 F, G) . Incubation with H1152 alone did not alter the amount of synaptic puncta colocalizing with p-MLC relative to the control condition (Fig.   3G ). Thus, in our experimental conditions, p-MLC did not result from endogenous ROCK activity. Conclusively, DETA/NO incubation increased colocalization of ROCK-ir puncta with p-MLC-ir structures apposed to the HMN plasma membrane (control, 0.3 Ϯ 0.1; DETA/NO, 1.1 Ϯ 0.3 colocalizing puncta/100 m; p ϭ 0.019) (Fig. 3 H, I ). Neither of these treatments significantly altered the frequency of syn-ir puncta apposed to HMNs (Fig. 3G) . Together, our data suggest that NO promotes MLC phosphorylation through a ROCK-dependent mechanism by activating sGC and subsequently PKG before synapse loss.
NO induces withdrawal of excitatory and inhibitory terminals from neonatal motoneurons
Given that de novo nNOS expression affected excitatory, but not inhibitory, synapses in adult HMNs and the molecular mechanism was scrutinized using neonatal slices, we next looked for a NO-induced selective action at the neonatal stage for an age-dependent effect. This could be the basis for synaptic refinement occurring during postnatal development. Long-term incubation (ϳ6 h) of slices with DETA/NO led to a reduction in both VGLUT2-(2.6 Ϯ 0.38 puncta/100 m) and VGAT-ir (13.3 Ϯ 0.75 puncta/100 m) puncta apposed to the motoneuron membrane (Fig. 4A-C) , even though excitatory were more profoundly affected than inhibitory synapses (VGLUT2, Ϫ60.9 Ϯ 5.73%; VGAT, Ϫ32.8 Ϯ 3.77%; p Ͻ 0.0001, unpaired two-tailed Student's t test). Electron microscopy analysis revealed that in HMNs from slices incubated with DETA/NO, the frequency of F/P-or S-type terminals was significantly reduced relative to the control aCSF condition (Fig. 4D-H) . Although both subtypes of synaptic terminals were reduced, boutons containing S vesicles (Ϫ79.2 Ϯ 9.11%) were proportionally more affected than those with F/P vesicles (Ϫ40.6 Ϯ 5.04%). In DETA/ NO-treated motoneurons, we frequently observed a wide membrane that lacked attached terminals and was covered by glial-like processes (Fig. 4G) . These results indicate that exogenous NO is able to induce synapse withdrawal within just 6 h. NO affects both excitatory and inhibitory synapses, with a more prominent effect on excitatory boutons contacting neonatal motoneurons in vitro.
Age-dependent paracrine action of NO on motoneuron loss of excitatory and inhibitory puncta NO shows differential selectivity for adult and neonatal motoneurons. One key question is whether this selectivity is acquired during postnatal development or results from differences in the NO sources provided at each stage. To evaluate these possibilities, we injected Av-eGFP/Av-nNOS into the tip of the tongue of neonatal rats (P3). Four to 6 d after adenoviral administration, VGLUT2-and VGAT-ir puncta were significantly and similarly reduced compared with AveGFP-transfected animals (VGAT, Ϫ66.3 Ϯ 3.31%; VGLUT2, Ϫ63.6 Ϯ 5.85%) (Fig.  5A-C) . These data point to an agedependent change in the vulnerability of synapses to NO.
We next investigated whether NO-induced synaptic elimination involved a paracrine/retrograde action. Av-eGFP/ Av-nNOS-transfected rat pups were treated daily with the NOS inhibitor L-NAME, beginning the day of adenoviral administration to minimize NO synthesis until slice extraction. The linear density of syn-ir puncta apposed to HMNs, obtained at P7 and incubated for 6 h in aCSF, was reduced (Ϫ47.1 Ϯ 5.8%) compared with FG-labeled HMNs incubated under the same conditions (Fig. 5D,G) . This effect was similar to that evoked by long-term incubation with DETA/NO (Ϫ48.9 Ϯ 1.7%), indicating that similar and/or saturating levels of NO could be achieved in both experimental models. However, under the continuous presence of L-NAME or the membrane-impermeable NO scavenger C-PTIO (Ko and Kelly, 1999) , the reduction in the frequency of syn-ir puncta was avoided (Fig. 5E-G) .
Functional approaches confirmed these results. The amplitude of evoked EPSPs obtained from eGFP-positive HMNs (Fig. 5H) was reduced (Ϫ66.7 Ϯ 7.4%) relative to nontransfected HMNs when slices were maintained for 5-6 h in aCSF. However, incubation with L-NAME or C-PTIO prevented EPSP attenuation (Ϫ3.7 Ϯ 15.0 and ϩ13.9 Ϯ 20.2%, respectively) (Fig. 5I,J) . These data indicate that synaptic reorganization around cotransfected HMNs resulted from NO synthesis during the incubation period after slice extraction, requiring a paracrine/retrograde action of NO on target structures.
NO-mediated synaptic withdrawal in a model of motoneuron pathology: motor nerve injury
XIIth nerve crushing induced both de novo expression of nNOS and a NO/cGMP-dependent synaptic loss on adult HMNs (Sunico et al., 2005) . One week after crushing, animals treated daily with the inactive stereoisomer D-NAME had a reduction in the frequency of VGLUT2-(3.4 Ϯ 0.29 puncta/100 m), but not in VGAT-ir (15.2 Ϯ 0.60 puncta/100 m) puncta compared with the intact side (VGLUT2, 6.5 Ϯ 0.45 puncta/100 m; VGAT, 14.5 Ϯ 0.72 puncta/100 m) (Fig. 6 A, B,D) . In contrast, chronic administration of the NOS inhibitor L-NAME avoided reduction in excitatory puncta (VGLUT2, 6.7 Ϯ 0.38 puncta/100 m; VGAT, 15.9 Ϯ 0.46 puncta/100 m) (Fig. 6 D) . Protective effects on the synaptic array were also obtained after nNOS or sGC inhibition with 7-NI or ODQ, respectively (Fig. 6C,D) . We next looked for glutamatergic inputs containing ROCK as feasible targets for the paracrine NO action. One week after unilateral XIIth nerve injury, in the intact (control) HN, ROCK-ir puncta of both isoforms, ROCK␣ and ROCK␤, were observed colocalizing and in close proximity to VGLUT2-ir puncta apposed to HMNs (Fig.  6 E) . This agrees with the regulatory role of ROCK in cytoskeleton dynamics and microtubule organization (Benarroch, 2007) . We found a dramatic decrease in the number of VGLUT2-ir related to ROCK-ir puncta on the injured side (VGLUT2/ROCK␣, Ϫ79.0 Ϯ 8.9%; VGLUT2/ROCK␤, Ϫ64.6 Ϯ 14.3%) (Fig. 6 E, F ) . Furthermore, the number of p-MLC-ir puncta in close proximity to injured HMNs increased at 4 d after injury (intact side, 3.5 Ϯ 0.6; injured side, 7.6 Ϯ 1.2 puncta/100 m; p Ͻ 0.01, unpaired two-tailed Student's t test; n ϭ 18 HMNs from 3 rats per condition). At this same time point, the percentage of syn-ir colocalizing with p-MLC-ir puncta apposed to injured HMNs considerably increased (intact side, 11.4 Ϯ 2.5%; injured side, 29.3 Ϯ 3.3%; p Ͻ 0.0001, unpaired two-tailed Student's t test) (Fig. 6G,H) . We selected this postinjury time window because nNOS was already upregulated (Sunico et al., 2005) and syn-ir reduction had not yet occurred (intact side, 16.9 Ϯ 0.55; injured side, 17.2 Ϯ 0.7 puncta/100 m). These results suggest that, after motor nerve injury in adult rats, NO, through sGC, mediates the loss of most ROCK-containing excitatory inputs, likely by a mechanism involving previous p-MLC.
Discussion
Our results indicate that nNOS upregulation in motoneurons is sufficient to induce synapse detachment at adult and neonatal Virally directed nNOS expression in neonatal HMNs reduces excitatory and inhibitory puncta by a paracrine/retrograde action of NO. A, B, VGAT-and VGLUT2-ir puncta around eGFP-transfected HMNs from animals at P6 -P9 after injection of the indicated Avs into the tongue at P3. Secondary antibodies were labeled with Cy5 and Cy3 for immunolabeling of VGAT and VGLUT2, respectively. C, Average number of VT-ir puncta per 100 m of HMN perimeter in eGFP-identified motoneurons from animals receiving the indicated mixture of Avs (Av-eGFP, n ϭ 28 HMNs from 3 pups; Av-eGFP/Av-nNOS, n ϭ 33 HMNs from 3 pups). D-F, Syn-ir puncta around eGFP-transduced HMNs at P6 -P9 in sections obtained from slices incubated for 6 h with aCSF (D), L-NAME (E), or C-PTIO (F ) from animals receiving the injection of Av-eGFP/Av-nNOS at P3 in the tip of the tongue. All animals received daily a subcutaneous injection of L-NAME beginning on the day of Av administration. Secondary antibody was labeled with Cy5 for immunolabeling of syn. G, Average change in linear density of syn-ir puncta on eGFP-identified HMNs under the indicated treatments (aCSF, n ϭ 14 HMNs from 3 pups; L-NAME, n ϭ 11 HMNs from 5 pups; C-PTIO, n ϭ 12 HMNs from 5 pups). In these experiments, the control condition was considered the same as in Figure 2 E. H, Whole-cell patch-clamp recordings were performed from eGFP-identified HMNs. Inset, DIC-infrared photomicrograph of the same transfected HMN immediately before gigaseal formation with a glass pipette. I, Representative traces (10 overlapped) of evoked EPSPs recorded in HMNs under the indicated conditions. The arrowheads point to the stimulus artifact. J, Average mean amplitude of the EPSP recorded under the indicated treatments (aCSF, n ϭ 8 HMNs from 3 pups; L-NAME, n ϭ 10 HMNs from 4 pups; C-PTIO, n ϭ 9 HMNs from 4 pups). In these experiments the control condition was considered the same as in Figure 2 H. *p Ͻ 0.0001, one-way ANOVA relative to the FG-identified HMNs incubated in aCSF. Error bars indicate SEM. Scale bar, 10 m.
stages. Paracrine action of NO on presynaptic structures, through sGC/PKG and RhoA/ROCK signaling, triggered synapse loss preceded by MLC phosphorylation. We contribute evidence that this molecular cascade was operational in a model of motoneuron pathology: after traumatic injury of a motor nerve. Gain in NO sources and/or synthesis could be a general mechanism targeting synapses expressing sGC/PKGRhoA/ROCK, which are selectively removed during brain development and early stages of several neurodegenerative diseases.
Transduction of adult motoneurons with eGFP plus nNOS induced a selective reduction in the linear density of VGLUT2-ir puncta and S-type boutons. Paradoxically, the array of VGAT-ir puncta or F/P-type boutons apposed to HMNs was unaltered. Thus, nNOS transfection mimicked the effect of axonal injury on the synaptic coverage of HMNs (i.e., a selective decrease in VGLUT2-ir puncta density and larger loss of S-type boutons) (Sumner, 1975) . However, it can be argued that nNOS upregulation in the muscle after adenoviral injection could actually trigger central synapse loss suffered by motoneurons. Notably, systemic nNOS inhibition prevented the effects of nerve damage on the synaptic arrangement even though neuromuscular communication was not yet reestablished at the tested time point (Sunico et al., 2008) . In slices obtained from neonatal eGFP plus nNOS-transfected pups chronically receiving L-NAME, reduction of syn-ir puncta apposed to HMNs occurred after long-term incubation in aCSF, but not in L-NAME-or C-PTIO (a NO scavenger)-supplemented medium. This indicates that NO from the transfected motoneuron induced synapse alterations through a paracrine/retrograde action. However, whether this paracrine action is sufficient remains elusive. Additionally, slices chronically incubated with DETA/NO, and therefore deprived of muscle influence, induced a strong decrease in VGATand VGLUT2-ir puncta apposed to and in F/P-and S-types boutons attached to motoneurons. Together, these findings strongly indicate that gain in neuronal NO signaling is sufficient to induce synapse detachment in adult and neonatal motoneurons.
The molecular cascade involved in NO-induced synapse elimination was investigated in vitro. Synapse loss induced in neonatal slices by long-term incubation with DETA/NO was prevented by coincubation with a sGC inhibitor. The preventive effect of the sGC inhibitor was also observed after motor nerve injury in adults. Therefore, NO-induced synaptic detachment is mediated by a cGMP-dependent mechanism in in vitro and in vivo preparations as well as at neonatal and adult stages. The NONOatedirected effect was also prevented by coaddition of a specific PKG Figure 6 . AxonalinjuryinducesaNO/cGMP-dependentreductionofVGLUT2/ROCK-irpunctaapposedtoadultmotoneuronspreceded byanincreaseinp-MLC.A-C,VGAT-ir(•)andVGLUT2-ir(*)punctaaroundFG-backlabeledHMNsobtainedfromintactanimals(A)and7d after XIIth nerve crushing treated daily with the indicated drugs. Secondary antibodies were labeled with Cy5 and Cy3 for immunolabeling ofVGATandVGLUT2,respectively.D,AveragenumberofVT-irpunctaper100mofHMNperimeterinFG-identifiedmotoneurons7dafter XIIthnervecrushingfromanimalsreceivingtheindicatedtreatments(control/intact,nϭ34HMNs;D-NAME,nϭ45HMNs;L-NAME,nϭ 33HMNs;7-NI,nϭ38HMNs;ODQ,nϭ30HMNs;from3animalsperexperimentalcondition).*pϽ0.0001,one-wayANOVAtestrelative to the control/intact group. E, Syn-ir and ROCK␣-or ROCK␤-ir puncta adjacent to SMI32-immunolabeled HMNs in the intact and crushed sides 7 d after XIIth nerve crushing. Secondary antibodies were labeled with Cy5 and Cy3 for immunolabeling of ROCK and VGLUT2, respectively. F, Average percentage of VGLUT2-ir puncta colocalizing with the indicated ROCK isoforms in the intact and crushed sides apposed to SMI32-identified HMNs 7 d after nerve injury (n ϭ 30 HMNs per condition and ROCK isoform). *p Ͻ 0.01, **p Ͻ 0.001, unpairedtwo-tailedStudent'sttest.ErrorbarsindicateSEM.G,H,Syn-ircolocalizingwithp-MLCpunctaapposedtoSMI32-immunolabeled HMNsinintactandinjuredsidesfromanimals4dafterunilateralXIIthnervecrushing.SecondaryantibodieswerelabeledwithCy5andCy3 for immunolabeling of syn and p-MLC, respectively. Scale bars, 10 m.
of NO, as achieved under incubation with 1 mM DETA/NO (ϳ1 M NO) (Abudara et al., 2002) , by hCMV-directed nNOS overexpression in motoneurons or in pathological nNOS upregulation induced by motoneuron axonal injury, could induce additional effects on NO-sensitive excitatory synapses. Nonetheless, we cannot dismiss the possibility of changes in presynaptic molecular composition during postnatal maturation lowering the NO threshold of excitatory inputs.
Axotomized HMNs upregulate nNOS and undergo excitatory synaptic stripping, which likely accounts for the strong reduction in their firing activities (Sunico et al., 2005) . Systemic administration of inhibitors of the neuronal NO/cGMP pathway prevented synapse loss. Motor nerve injury induced an increase in the number of syn/p-MLC-positive puncta, before synapse detachment, followed by a strong reduction in VGLUT2/ROCKpositive puncta around adult injured HMNs. A decrease in synaptic density together with overexpression and/or de novo expression of nNOS are early common hallmarks in several neurodegenerative diseases. In the spinal cord of SOD1 G93A mice, ROCK␣ is overexpressed (Hu et al., 2003) , suggesting an increase in RhoA/ROCK signaling. In addition, a ROCK inhibitor has been recently described as a therapeutic lead in HD (Shao et al., 2008) . Interestingly, the pattern of neurodegeneration in the AD brain is consistent with a model in which synaptic scaling is the driving force for disease progression (Small, 2008) . A selective elimination of glutamatergic synapses on striatopallidal neurons occurs in PD models (Day et al., 2006) , a promising connection with what happens in adult nNOS-expressing motoneurons. These additional data support the possibility that the action mechanism underlying synapse loss described here could be common to several neurodegenerative diseases.
We propose here a mechanism of action triggered by nNOS upregulation in the course of diverse pathological conditions of the nervous system underlying synapse reduction (Fig. 7) . NO production is coupled with Ca 2ϩ influx through NMDA subtype receptor (Garthwaite et al., 1988) and is also effected by non-NMDA receptor agonists (Wood et al., 1990) . Axonal injury of motoneurons increases NMDA expression and completely depletes the GluR2 subunit of AMPA receptors (García Del Caño et al., 2000) , which prevents Ca 2ϩ influx through them (Hollmann et al., 1991) . Thus, in impaired neurons, more sources are available to increase intracellular Ca 2ϩ concentration, which in turn may facilitate NO production via Ca 2ϩ /calmodulin-mediated nNOS activation (Fig. 7) . As a gas, pathological NO from sick neurons can, by a paracrine action, induce retraction of neighboring synapses whether they have the appropriate molecular substrate. This could explain why not all synapses are lost in pathological conditions around nNOS-expressing neurons. NO activating sGC increases intrasynaptic cGMP level that, in turn, activates PKG. Directly or indirectly, PKG stimulates RhoA/ ROCK signaling. ROCK activation results in MLC phosphorylation either by a direct action on MLC and/or by activation of MLC-kinase and/or by inhibition of MLC-phosphatase (Benarroch, 2007) . Subsequently, p-MLC, as a regulatory factor, favors actomyosin contraction, which eventually contributes to bouton retraction.
